Trials / Withdrawn
WithdrawnNCT06075511
A Study of Sleeve Gastrectomy Risks and Benefits
Prospective Study to Assess Fitness in Patients with Renal Failure Undergoing Sleeve Gastrectomy - PROFIT
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study is being conducted to collect information to improve the outcomes of patients who have renal failure and are scheduled to have a sleeve gastrectomy.
Detailed description
We will collect information on changes in physical performance, activity, blood pressure and glucose metabolism, body composition, and the quality of life prior to and three months after sleeve gastrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 6 minutes walk distance | Subjects walk as far as possible for 6 minutes at a self-selected pace, and the total distance walked will be recorded |
| BEHAVIORAL | Activity Monitor | Subjects will wear an Actigraph on their wrist like a watch for up to 10 days at home to monitor activity. |
| BEHAVIORAL | Continuous Glucose Monitor | Subjects will collect glucose values in the fluid under their skin for up to 10 days at home. |
| BEHAVIORAL | Blood Pressure Monitoring | Subjects will monitor their blood pressure at home for 10 consecutive days 3 times a day |
| DIAGNOSTIC_TEST | Blood Pressure Monitoring | 24-hour ambulatory blood pressure monitoring |
| DIAGNOSTIC_TEST | Body Composition Scan | Measure of body fat percentage, skeletal muscle mass, body water, and visceral fat. |
| DIAGNOSTIC_TEST | Mixed meal testing | Subjects will consume 6 ml/kg body weight of Boost, up to maximum of 360 ml, within 5 min |
| DIAGNOSTIC_TEST | Quality of Life | Subject will complete Quality of Life Questionnaire |
Timeline
- Start date
- 2025-03-01
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2023-10-10
- Last updated
- 2025-01-30
Source: ClinicalTrials.gov record NCT06075511. Inclusion in this directory is not an endorsement.